MétaCan
Menu
Back to cohort
Record W2180295246 · doi:10.2217/bmt.15.2

Exemestane for Breast Cancer Risk Reduction

2015· article· en· W2180295246 on OpenAlexaff
Rachel Jorge Dino Cossetti, Karen A. Gelmon

Bibliographic record

VenueBreast Cancer Management · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicEstrogen and related hormone effects
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsExemestaneMedicineRaloxifeneBreast cancerTamoxifenAromataseOncologyInternal medicinePopulationSelective estrogen receptor modulatorCancerGynecology

Abstract

fetched live from OpenAlex

SUMMARY Chemoprevention of estrogen receptor (ER)-positive invasive breast cancers is a feasible maneuver with the use of the selective ER modulators tamoxifen and raloxifene. However, their uptake as chemoprevention agents has remained low, mainly due to concerns about toxicity, and specifically the risk of thromboembolism and endometrial carcinomas. Aromatase inhibitors have not been associated with these potentially serious complications. Exemestane is a steroidal aromatase inhibitor recently studied in the randomized MAP.3 trial for breast cancer chemoprevention in a high-risk population. After 3 years of follow-up, the incidence of invasive breast cancer was reduced by 65% and the incidence of ER-positive invasive breast cancers by 73%. The risk of osteoporosis and cardiovascular events was not higher with exemestane. Longer follow-up is warranted, but exemestane can be considered an option for the chemoprevention of breast cancer in a high-risk postmenopausal female population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.008
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0080.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.260
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueBreast Cancer ManagementSame topicEstrogen and related hormone effectsFrench-language works237,207